Identification of human brain tumour initiating cells

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Nature

• Publication date

  2004-11-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature03128PMID 15549107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma

  2004cited by this paper
• Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity

  2004cited by this paper
• Getting at the root and stem of brain tumors.

  2004cited by this paper
• Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.

  2004cited by this paper
• Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2

  2003cited by this paper
• Cancerous stem cells can arise from pediatric brain tumors

  2003cited by this paper
• Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.

  2003cited by this paper
• Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

  2003cited by this paper
• Identification of a cancer stem cell in human brain tumors.

  2003cited by this paper
• Breast cancer stem cells revealed

  2003cited by this paper
• Applying the principles of stem-cell biology to cancer

  2003cited by this paper
• Scale Dependency of Rarity, Extinction Risk, and Conservation Priority

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitro

  2002cited by this paper
• Internal structure and patterns of contraction in the geographic range of the Iberian lynx

  2002cited by this paper
• The WHO Classification of Tumors of the Nervous System

  2002cited by this paper
• Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis.

  2002cited by this paper
• Gliomagenesis: genetic alterations and mouse models

  2001cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Rapid responses of British butterflies to opposing forces of climate and habitat change

  2001cited by this paper
• Human trophoblast contains an intracellular protein reactive with an antibody against CD133--a novel marker for trophoblast.

  2001cited by this paper
• Butterfly diversity loss in Flanders (north Belgium): Europe's worst case scenario?

  2001cited by this paper
• Pathology of Tumors of the Central Nervous System

  2001cited by this paper
• Making Consistent IUCN Classifications under Uncertainty

  2000cited by this paper
• Direct isolation of human central nervous system stem cells.

  2000cited by this paper
• Self-similarity and clustering in the spatial distribution of species.

  2000cited by this paper
• Dynamic biogeography and conservation of endangered species

  2000cited by this paper
• Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.

  2000cited by this paper
• Spatial patterns in the distribution of tropical tree species.

  2000cited by this paper
• Sensitivity analyses of decision rules in World Conservation Union (IUCN) Red List criteria using Australian plants

  2000cited by this paper
• Geographic range structure in North American landbrids: variation with migratory strategy, trophic level, and breeding habitat

  2000cited by this paper
• Flight areas of British butterflies: assessing species status and decline

  1999cited by this paper
• Climate and habitat availability determine 20th century changes in a butterfly's range margin

  1999cited by this paper
• Time Lag between Deforestation and Bird Extinction in Tropical Forest Fragments

  1999cited by this paper
• A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.

  1998cited by this paper
• AC133 hematopoietic stem cell antigen: human homologue of mouse kidney prominin or distinct member of a novel protein family?

  1998cited by this paper
• Species extinction and the relationship between distribution and abundance

  1998cited by this paper
• Extrapolating species abundance across spatial scales

  1998cited by this paper
• Assessing national conservation priorities: an improved red list of British butterflies

  1997cited by this paper
• A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.

  1997cited by this paper
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

  1997cited by this paper
• Phylogenies and the Comparative Method: A General Approach to Incorporating Phylogenetic Information into the Analysis of Interspecific Data

  1997cited by this paper
• Spatial Variation in Abundance

  1995cited by this paper
• Estimating rates of butterfly decline from distribution maps: The effect of scale

  1995cited by this paper
• A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

  1994cited by this paper
• Assessing Extinction Threats: Toward a Reevaluation of IUCN Threatened Species Categories

  1991cited by this paper
• CNS stem cells express a new class of intermediate filament protein.

  1990cited by this paper
• Human brain tumor xenografts in nude mice as a chemotherapy model.

  1983cited by this paper

• Update on glioblastoma: Biology, clinical management and emerging therapeutic strategies (Review)

  2026influential citation
• The functional imperative in high-grade glioma

  2026cites this paper
• ENOX2 (tNOX)–Associated Stemness in Oral Cancer Cells and Its Clinical Correlation in Head and Neck Tumors

  2026cites this paper
• A different perspective on the cancer stem cell theory.

  2026cites this paper
• Neural stem cells and glioblastoma stem cells: redefining concepts.

  2026cites this paper
• Aptamer–liposome targeted nanotherapeutics for cancer therapy: Bibliometric analysis, recent developments and future perspectives

  2026cites this paper
• Predictable clonal hierarchies from restricted progenitors provide a framework for cell type-specific therapies in glioblastoma

  2026cites this paper
• A first-in-class small-molecule inhibitor targeting AVIL exhibits safety and antitumor efficacy in preclinical models of glioblastoma.

  2026cites this paper
• Connexin-Pannexin duality in glioblastoma

  2026cites this paper
• Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine

  2026cites this paper
• Identification of prognostic biomarkers and development of a prediction model for prostate cancer

  2026cites this paper
• Targeting MGAT4A‐Mediated N‐Glycosylation as a Therapeutic Strategy to Inhibit Glioblastoma Stem Cell Invasion

  2026cites this paper
• Modeling pediatric brain tumors with human stem cells.

  2026cites this paper
• Disruption of the NDC80-Nek2 axis suppresses glioblastoma stemness and enhances therapeutic efficacy.

  2026cites this paper
• Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target.

  2026cites this paper
• Practical and translational therapeutic elements for GBM therapy.

  2026cites this paper
• Clinical and genetic determinants of glioblastoma survival: a retrospective study

  2026cites this paper
• SOX21 suppresses glioblastoma growth by repressing AP-1 activity

  2026cites this paper
• Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progression

  2025cites this paper
• GABAergic Influences on Medulloblastoma

  2025cites this paper
• Progenitor cells, microglia, and non-coding RNAs: Orchestrators of glioblastoma pathogenesis and therapeutic resistance

  2025cites this paper
• CircMAN1A2 Levels Determine GBM Susceptibility to TMZ in a Pathway Involving TEP1‐ and KEAP1‐Mediated NRF2 Degradation Leading to Ferroptosis

  2025cites this paper
• Using GlioVis to Explore, Analyze, and Visualize Brain Tumor Multi-Omics Datasets.

  2025cites this paper
• Etorkizuneko farmako-menua: Burmuineko minbizidun haurrentzako medikuntza pertsonalizaturako plataforma aurreratua

  2025cites this paper
• Growth Dynamics of Brain Tumor Through the Lens of MT-Weighted MRI.

  2025cites this paper
• Origins of Glioblastoma: Initiation and Molecular Signatures of Extreme Aggressiveness

  2025cites this paper
• The reprogramming impact of SMAC-mimetic on glioblastoma stem cells and the immune tumor microenvironment evolution

  2025cites this paper
• Mitochondrial Calcium Uniporter Links Acetyl-CoA Metabolism and H3K27 Acetylation to Maintain Glioblastoma Stem Cells.

  2025cites this paper
• Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions

  2025cites this paper
• Cellular heterogeneity and therapeutic response profiling of human IDH+ glioma stem cell cultures

  2025cites this paper
• In Vitro Models to Compare the Duration of Action of New Therapeutic Scaffolds and Drug Eluting Medical Devices.

  2025cites this paper
• Inhibition of CD133 resulted in cell death, inhibition of angiogenesis, and limited migration in the melanoma cancer cell line

  2025cites this paper
• Integration of Single‐Cell RNA and Bulk RNA Sequencing Reveals Cellular Heterogeneity and Identifies Survival‐Associated Regulatory Networks in Glioblastoma

  2025cites this paper
• Role of the bone marrow microenvironment in multiple myeloma: Impact of niches on drug resistance mechanisms.

  2025cites this paper
• The GD3 ganglioside promotes cell growth, plasticity and chemotherapy resistance of human glioblastoma cancer stem cells

  2025cites this paper
• Targeting the Cargo Receptor TMED9 as a Therapeutic Strategy Against Brain Tumors

  2025cites this paper
• S-palmitoylation of c-MET by CK2α-mediated zDHHC15 phosphorylation drives glioblastoma stem cell tumorigenicity.

  2025cites this paper
• Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells

  2025cites this paper
• Phospholipid Metabolism Reprogramming of Cancer Stem Cells and Its Impacts on Stemness

  2025cites this paper
• Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions

  2025cites this paper
• Integrin targeted photodynamic therapy in patient‐derived glioblastoma spheroids

  2025cites this paper
• Nanotherapeutic strategies exploiting biological traits of cancer stem cells

  2025cites this paper
• Modeling of cancer stem cells and the tumor microenvironment Via NT2/D1 cells to probe pathology and treatment for cancer and beyond

  2025cites this paper
• Hyperbaric oxygen promotes both the proliferation and chemosensitization of glioblastoma cells by inhibiting HIF1α/HIF2α-ABCG2

  2025cites this paper
• Targeting Glioma Stem Cells: Therapeutic Opportunities and Challenges

  2025influential citation
• Stress-induced pro-inflammatory glioblastoma stem cells secrete TNFAIP6 to enhance tumor growth and induce suppressive macrophages.

  2025cites this paper
• Nuclear cholesterol regulates nuclear size and DNA damage responses in cancer stem cells.

  2025cites this paper
• The significance of epithelial–mesenchymal transition (EMT) in the initiation, plasticity, and treatment of glioblastoma

  2025cites this paper
• Isolation and Propagation of Brain Tumor Stem Cells.

  2025cites this paper
• A Toolkit for Single-Nucleus Characterization of Glioblastoma.

  2025cites this paper
• O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation Analysis in Glioblastoma Patients.

  2025cites this paper
• Unmasking Stemness and Immune Cell Markers in Brain Tumors with Immunohistochemistry.

  2025cites this paper
• Brain Tumor Stem Cells: New Perspectives.

  2025cites this paper
• Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities

  2025cites this paper
• New approaches to overcome radioresistance in glioblastoma: mechanisms, targets and role of innovative therapies, new particles and non-photon radiotherapy in 2024. A systematic review

  2025cites this paper
• Genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis

  2025cites this paper
• Extracellular Vesicles Administered via Intrathecal Injection Mediate Safe Delivery of Nucleic Acids to the Central Nervous System for Gene Therapy

  2025cites this paper
• Cluster of differentiation 133 (CD133) and C-X-C chemokine receptor 4 (CXCR4) associated with the incidence of metastasis in osteosarcoma patients

  2025cites this paper
• Molecular drivers in primary brain tumor formation.

  2025cites this paper
• Combination Treatment of Docetaxel with Phytol or Thymol Additively Inhibits the Proliferation of Breast Cancer Cells and Downregulates the Expression of Cancer Stem Cell Markers

  2025cites this paper
• Cancer stem cell biomarkers in locally advanced head and neck squamous cell carcinoma

  2025cites this paper
• Modeling glioma intratumoral heterogeneity with primary human neural stem and progenitor cells

  2025cites this paper
• Kinase-Targeted Therapies for Glioblastoma

  2025cites this paper
• Optimized culturing yields high success rates and preserves molecular heterogeneity, enabling personalized screening for high-grade gliomas

  2025cites this paper
• Bioinformatics tools and experimental analysis combination for production of specific scFv against CD133

  2025cites this paper
• NUP98‐p65 complex regulates DNA repair to maintain glioblastoma stem cells

  2025cites this paper
• MiR-326: Role and significance in brain cancers

  2025cites this paper
• Joint analysis of single-cell RNA sequencing and bulk transcriptome reveals the heterogeneity of the urea cycle of astrocytes in glioblastoma.

  2025cites this paper
• OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma

  2025cites this paper
• Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile

  2025cites this paper
• Human RAP2A homolog of the Drosophila asymmetric cell division regulator Rap2l targets the stemness of glioblastoma stem cells

  2025cites this paper
• Combinational Inhibition of MEK and AKT Synergistically Induces Melanoma Stem Cell Apoptosis and Blocks NRAS Tumor Growth

  2025cites this paper
• Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targets

  2025cites this paper
• Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma

  2025cites this paper
• U87 Glioblastoma Cell-Derived Extracellular Vesicle Mediated Dysregulation of Angiogenic Mediators in Endothelial Cells: An In Silico and In Vitro Analysis

  2025cites this paper
• Raman Spectroscopies for Cancer Research and Clinical Applications: a Focus on Cancer Stem Cells.

  2025cites this paper
• The influence of extracellular vesicles on tumor evolution and resistance to therapy.

  2025cites this paper
• The Erosion of Healthcare and Scientific Integrity: A Growing Concern

  2025cites this paper
• Deciphering FOXM1 regulation: implications for stemness and metabolic adaptations in glioblastoma

  2025cites this paper
• Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer

  2025cites this paper
• An OSMR-CLIC1 cross talk drives key oncogenic pathways in glioblastoma

  2025cites this paper
• Testes-specific protease 50 heightens stem-like properties and improves mitochondrial function in colorectal cancer.

  2025cites this paper
• The Intersections between Neuroscience and Medulloblastoma.

  2025cites this paper
• In vitro investigation of epigenetic regulators related to chemo-resistance and stemness of CD133+VE cells sorted from U87MG cell line.

  2025cites this paper
• The Role of Medicinal Plants in Modulating Epigenetic Mechanisms: Implications for Cancer Prevention and Therapy

  2025cites this paper
• Epigenetics and cancer stem cells-The world of cancer genesis: A review.

  2025cites this paper
• Loss of CARM1 alters the developmental programming of Glioma stem-like cells and creates a druggable NGFR/NTRK dependency

  2025cites this paper
• Synthetic lethality through Gsk3β inhibition in glioma stem cells via the WNT-WWC1-YAP axis

  2025cites this paper
• Breaking the Resistance: Photodynamic Therapy in Cancer Stem Cell-Driven Tumorigenesis

  2025cites this paper
• Circulating tumor cells in lung cancer: Integrating stemness and heterogeneity to improve clinical utility.

  2025cites this paper
• Lactylation as a metabolic epigenetic modification: Mechanistic insights and regulatory pathways from cells to organs and diseases.

  2025cites this paper
• Comparison of the biological characteristics of glioblastoma tumorspheres obtained from fresh and cryopreserved glioblastoma tissues

  2025cites this paper
• IGFBP-2 and IGF-II: Key Components of the Neural Stem Cell Niche? Implications for Glioblastoma Pathogenesis

  2025cites this paper
• GliaTrap is a biodegradable, non-swelling and non-inflammatory hydrogel with tuned release of CXCL12 to attract migrating glioblastoma cells

  2025cites this paper
• Cancer stem cells amino acid metabolism: Roles, mechanisms, and intervention strategies.

  2025cites this paper
• N-Heterocyclic carbene platinum complexes encapsulated in lipid particles: a novel strategy to target cancer cells and cancer stem cells in glioblastoma

  2025cites this paper
• Research Progress on Surface Markers of Glioma Cancer Stem Cells and Related Targeted Therapeutic Strategies

  2025cites this paper
• Acquired resistance to molecularly targeted therapies for cancer

  2025cites this paper
• Endothelial cells-derived SEMA3G suppresses glioblastoma stem cells by inducing c-Myc degradation

  2025cites this paper
• Inhibition of Thioredoxin-Reductase by Auranofin as a Pro-Oxidant Anticancer Strategy for Glioblastoma: In Vitro and In Vivo Studies

  2025cites this paper